DANIEL WEIS: Open Payments
NPI 1811967672 · MIDDLETOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,143 in 120 payments from 12 companies in 2025. Trend: 2023 $1,712 · 2024 $1,850 · 2025 $2,143
Food & beverage: $2,139Education: $4
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 29 | $425 |
| Teva Pharmaceuticals USA, Inc. | 23 | $398 |
| Lundbeck LLC | 15 | $324 |
| E.R. Squibb & Sons, L.L.C. | 21 | $264 |
| Janssen Pharmaceuticals, Inc | 8 | $192 |
| Axsome Therapeutics, Inc. | 4 | $178 |
| Otsuka America Pharmaceutical, Inc. | 5 | $94 |
| Neurocrine BioSciences, Inc. | 4 | $79 |
| ABBVIE INC. | 3 | $61 |
| Supernus Pharmaceuticals, Inc. | 3 | $47 |
Products named: ARISTADA, AUSTEDO XR, COBENFY, REXULTI, ABILIFY MAINTENA, Auvelity, INVEGA SUSTENNA, UZEDY.
Industry payments across OH — which companies pay providers there.
